Published in Cancer Epidemiol Biomarkers Prev on February 16, 2010
ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol (2015) 3.19
"You don't have to keep everything on paper": African American women's use of family health history tools. J Community Genet (2013) 0.92
Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer. J Clin Oncol (2016) 0.81
The context of collecting family health history: examining definitions of family and family communication about health among African American women. J Health Commun (2015) 0.78
Family history of breast and ovarian cancer and triple negative subtype in hispanic/latina women. Springerplus (2014) 0.78
An internal performance assessment of CancerGene Connect: an electronic tool to streamline, measure and improve the genetic counseling process. J Genet Couns (2014) 0.78
Family health information sharing among older adults: reaching more family members. J Community Genet (2014) 0.77
A model for patient-direct screening and referral for familial cancer risk. Fam Cancer (2016) 0.75
The family history--more important than ever. N Engl J Med (2004) 8.35
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol (2003) 5.69
Variance estimation for complex surveys using replication techniques. Stat Methods Med Res (1996) 3.96
Can family history be used as a tool for public health and preventive medicine? Genet Med (2002) 3.76
Reconsidering the family history in primary care. J Gen Intern Med (2004) 3.50
American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin (2006) 3.46
Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA (2004) 2.99
Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med (2003) 2.99
Concise handbook of familial cancer susceptibility syndromes - second edition. J Natl Cancer Inst Monogr (2008) 2.29
Developing Family Healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis (2008) 2.20
New standards and enhanced utility for family health history information in the electronic health record: an update from the American Health Information Community's Family Health History Multi-Stakeholder Workgroup. J Am Med Inform Assoc (2008) 2.14
Bias in using family history as a risk factor in case-control studies of disease. Epidemiology (1995) 2.03
Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention. Genet Med (2006) 1.77
Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. J Genet Couns (2004) 1.69
Familial risk for common diseases in primary care: the Family Healthware Impact Trial. Am J Prev Med (2009) 1.62
Reported family history of cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol (2003) 1.52
Collection and use of cancer family history in primary care. Evid Rep Technol Assess (Full Rep) (2007) 1.46
The comprehensiveness of family cancer history assessments in primary care. Community Genet (2007) 1.42
Cancer risk assessment from family history: gaps in primary care practice. J Fam Pract (2002) 1.31
Cancer risk assessment: quality and impact of the family history interview. Am J Prev Med (2004) 1.30
Confronting genetic testing disparities: knowledge is power. JAMA (2005) 1.26
Family history questionnaires designed for clinical use: a systematic review. Public Health Genomics (2008) 1.23
Underreporting of family history of colon cancer: correlates and implications. Cancer Epidemiol Biomarkers Prev (1999) 1.18
Cancer risk assessment: examining the family physician's role. J Am Board Fam Med (2006) 1.15
Family history of cancer: is it an accurate indicator of cancer risk in the immigrant population? Cancer (2008) 1.05
Healthy choices through family history: a community approach to family history awareness. Community Genet (2008) 1.00
Increased cancer risk for individuals with a family history of prostate cancer, colorectal cancer, and melanoma and their associated screening recommendations and practices. Cancer Causes Control (2007) 0.95
Patients with a family history of cancer: identification and management. J Am Board Fam Pract (2005) 0.95
Racial and gender disparities in hereditary colorectal cancer risk assessment: the role of family history. J Cancer Educ (2006) 0.95
Race and family history assessment for breast cancer. J Gen Intern Med (2005) 0.87
Population estimates of extended family structure and size. Community Genet (2008) 0.86
An overview of ethnicity and assessment of family history in primary care settings. J Am Acad Nurse Pract (2006) 0.84
Stability of self-reported family history of prostate cancer among African American men. J Nurs Meas (2002) 0.83
Achieving utility with family history: colorectal cancer risk. Am J Prev Med (2003) 0.83
Family history: the first genetic screen. Nurse Pract (2004) 0.81
Cancer genetics in primary care. Prim Care (2004) 0.77
Excess deaths associated with underweight, overweight, and obesity. JAMA (2005) 22.17
Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA (2013) 18.86
Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA (2007) 11.50
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis (2006) 7.98
Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med (2009) 6.42
The Health Information National Trends Survey (HINTS): development, design, and dissemination. J Health Commun (2004) 6.24
A victory for science and common sense. Br Dent J (2006) 6.08
Prevalence of oral HPV infection in the United States, 2009-2010. JAMA (2012) 6.02
The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature (2012) 5.61
Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr (2008) 5.01
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet (2010) 4.96
The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science (2007) 4.90
Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst (2007) 4.89
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Graphene plasmonics for tunable terahertz metamaterials. Nat Nanotechnol (2011) 4.20
Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol (2005) 4.10
Cancer incidence in persons with Fanconi anemia. Blood (2002) 4.05
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA (2012) 3.85
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst (2012) 3.69
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet (2007) 3.63
Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum (2002) 3.63
Eating out in America, 1987-2000: trends and nutritional correlates. Prev Med (2004) 3.55
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet (2008) 3.41
Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol (2005) 3.25
Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology (2011) 3.24
High adiposity and high body mass index-for-age in US children and adolescents overall and by race-ethnic group. Am J Clin Nutr (2010) 3.22
Methods of calculating deaths attributable to obesity. Am J Epidemiol (2004) 3.15
Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol (2010) 3.09
Assessment of the accuracy of portion size reports using computer-based food photographs aids in the development of an automated self-administered 24-hour recall. J Am Diet Assoc (2010) 2.95
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol (2007) 2.90
Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol (2013) 2.89
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera. Cancer Cell (2008) 2.80
Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA (2005) 2.71
Body mass index categories in observational studies of weight and risk of death. Am J Epidemiol (2014) 2.62
Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol (2008) 2.56
Evaluation of the American Stop Smoking Intervention Study (ASSIST): a report of outcomes. J Natl Cancer Inst (2003) 2.54
Trends in black-white differentials in dietary intakes of U.S. adults, 1971-2002. Am J Prev Med (2007) 2.52
The Automated Self-Administered 24-hour dietary recall (ASA24): a resource for researchers, clinicians, and educators from the National Cancer Institute. J Acad Nutr Diet (2012) 2.48
Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst (2003) 2.48
Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst (2006) 2.42
Secular trends in patterns of self-reported food consumption of adult Americans: NHANES 1971-1975 to NHANES 1999-2002. Am J Clin Nutr (2006) 2.40
Dietary patterns and adenocarcinoma of the esophagus and distal stomach. Am J Clin Nutr (2002) 2.40
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet (2013) 2.39
Competing risks analysis of correlated failure time data. Biometrics (2007) 2.31
Applying network theory to epidemics: control measures for Mycoplasma pneumoniae outbreaks. Emerg Infect Dis (2003) 2.30
Concise handbook of familial cancer susceptibility syndromes - second edition. J Natl Cancer Inst Monogr (2008) 2.29
The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet (2005) 2.26
Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Hum Mol Genet (2006) 2.23
Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. J Pharmacol Exp Ther (2008) 2.17
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet (2009) 2.13
Confirmation of family cancer history reported in a population-based survey. J Natl Cancer Inst (2011) 2.13
Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. J Clin Oncol (2005) 2.11
Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers. Breast Cancer Res Treat (2014) 2.10
Secular trends in the association of socio-economic position with self-reported dietary attributes and biomarkers in the US population: National Health and Nutrition Examination Survey (NHANES) 1971-1975 to NHANES 1999-2002. Public Health Nutr (2007) 2.07
Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environ Health Perspect (2006) 2.07
Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey. Cancer (2010) 2.05
Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older. J Clin Oncol (2011) 2.00
Reverse causation and illness-related weight loss in observational studies of body weight and mortality. Am J Epidemiol (2010) 1.99
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomarkers Prev (2011) 1.99
A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association. Cancer Res (2010) 1.98
An application of a weighting method to adjust for nonresponse in standardized incidence ratio analysis of cohort studies. Ann Epidemiol (2005) 1.96
Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVS. Infect Immun (2006) 1.93
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res (2010) 1.90
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet (2013) 1.88
Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis (2007) 1.88
Which women aren't getting mammograms and why? (United States). Cancer Causes Control (2007) 1.85
Reliability and validity of the Past Year Total Physical Activity Questionnaire. Am J Epidemiol (2006) 1.82
Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev (2008) 1.80
Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat Med (2011) 1.79
IL-1 family nomenclature. Nat Immunol (2010) 1.79
Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines. CA Cancer J Clin (2007) 1.77
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiol Biomarkers Prev (2007) 1.75
Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet (2013) 1.74
Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour. J Med Genet (2011) 1.73
Estimates of excess deaths associated with body mass index and other anthropometric variables. Am J Clin Nutr (2009) 1.73
An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer (2013) 1.71
The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred. Urol Oncol (2009) 1.70
Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women. Cancer Epidemiol Biomarkers Prev (2010) 1.66
Dietary patterns predict mortality in a national cohort: the National Health Interview Surveys, 1987 and 1992. J Nutr (2004) 1.64
Intakes of plain water, moisture in foods and beverages, and total water in the adult US population--nutritional, meal pattern, and body weight correlates: National Health and Nutrition Examination Surveys 1999-2006. Am J Clin Nutr (2009) 1.64
Cancer in Fanconi anemia. Blood (2003) 1.63
Hypertension and risk of renal cell carcinoma among white and black Americans. Epidemiology (2011) 1.61
Large prospective investigation of meat intake, related mutagens, and risk of renal cell carcinoma. Am J Clin Nutr (2011) 1.60
Statistical methods in the Global Enteric Multicenter Study (GEMS). Clin Infect Dis (2012) 1.59
Understanding intestinal cysteamine bitartrate absorption. J Pediatr (2006) 1.57
Characteristics of health information gatherers, disseminators, and blockers within families at risk of hereditary cancer: implications for family health communication interventions. Am J Public Health (2009) 1.57
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS Genet (2010) 1.56
Contributors of water intake in US children and adolescents: associations with dietary and meal characteristics--National Health and Nutrition Examination Survey 2005-2006. Am J Clin Nutr (2010) 1.55
Increasing incidence of testicular germ cell tumors among black men in the United States. J Clin Oncol (2005) 1.55
Correcting bias, or biased corrections? Obesity (Silver Spring) (2008) 1.54
Cigarette smoking and renal cell carcinoma risk among black and white Americans: effect modification by hypertension and obesity. Cancer Epidemiol Biomarkers Prev (2012) 1.54